HEPA Price / Book | HEPION PHARMACEUTICALS, INC.

Hepion Pharmaceuticals, Inc. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

Hepion Pharmaceuticals, Inc. price/book ratio for the quarter ending 2026-06-30 was 1.55, a 532.59% increase year-over-year.
Hepion Pharmaceuticals, Inc. price/book ratio for the quarter ending 2026-03-31 was 0.36, a 66.29% decline year-over-year.
Hepion Pharmaceuticals, Inc. price/book ratio for the quarter ending 2025-12-31 was 0.26, a change of 2.02 year-over-year.
Hepion Pharmaceuticals, Inc. price/book ratio for the quarter ending 2025-09-30 was 0.17, a 99.97% decline year-over-year.
Hepion Pharmaceuticals, Inc. price/book ratio for fiscal 2026 was 1.55.
Hepion Pharmaceuticals, Inc. price/book ratio for fiscal 2025 was 0.26, a change of 2.02 from fiscal 2024.
Hepion Pharmaceuticals, Inc. price/book ratio for fiscal 2024 was -1.76, a 181.85% decline from fiscal 2023.
Hepion Pharmaceuticals, Inc. price/book ratio for fiscal 2023 was 2.14, a 90.65% decline from fiscal 2022.

Available history: 2014-03-31 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	1.55	$1.98M	$1.28M
2026-03-31	0.36	$662,358.07	$1.86M
2025-12-31	0.26	$697,219.02	$2.67M
2025-09-30	0.17	$581,015.85	$3.32M
2025-06-30	0.24	$929,625.36	$3.8M
2025-03-31	1.06	$4.12M	$3.9M
2024-12-31	-1.76	$3.27M	-$1.86M
2024-09-30	573.18	$233.11M	$406,685.00
2024-06-30	83.03	$295.76M	$3.56M
2024-03-31	90.59	$681.4M	$7.52M
2023-12-31	2.14	$15.61M	$7.28M
2023-09-30	59.27	$957.65M	$16.16M
2023-06-30	76.41	$2.02B	$26.37M
2023-03-31	79.71	$2.96B	$37.15M
2022-12-31	22.93	$1.14B	$49.86M
2022-09-30	649.62	$38.5B	$59.26M
2022-06-30	648.83	$43.68B	$67.32M
2022-03-31	1,135.05	$98.34B	$86.64M
2021-12-31	934.42	$86.9B	$93M
2021-09-30	1,136.21	$116.62B	$102.64M
2021-06-30	1,363.07	$150.93B	$110.72M
2021-03-31	1,192.84	$140.25B	$117.58M
2020-12-31	1,730.86	$70.14B	$40.52M
2020-09-30	2,180.43	$28.07B	$12.87M
2020-06-30	1,456.38	$25.81B	$17.72M
2020-03-31	590.76	$10.75B	$18.2M
2019-12-31	1,290.6	$20.15B	$15.62M
2019-09-30	523.15	$8.36B	$15.98M
2019-06-30	810.03	$14.4B	$17.78M
2019-03-31	829,406.26	$327.44B	$394,792.00
2018-12-31	2,827.02	$4.88B	$1.72M
2018-09-30	137,653.44	$640.7B	$4.65M
2018-06-30	-1,292,885.1	$972.99B	-$752,571.00
2018-03-31	3,664,077.19	$11.18T	$3.05M
2017-12-31	533,103.89	$1.97T	$3.7M
2017-09-30	4,559,201.37	$22.76T	$4.99M
2017-06-30	2,714,739.2	$24.59T	$9.06M
2017-03-31	-163,837,879.88	$63.15T	-$385,422.00
2016-12-31	7,177,669.4	$42.19T	$5.88M
2016-09-30	-11,118,311.07	$33.31T	-$3M
2016-06-30	14,246,933.59	$18.77T	$1.32M
2016-03-31	14,281,782.35	$18.5T	$1.3M
2015-12-31	4,722,590.73	$23.54T	$4.98M
2015-09-30	-19,171,616.21	$26.09T	-$1.36M
2015-06-30	18,427,244.44	$63.37T	$3.44M
2015-03-31	4,872,890.85	$38.42T	$7.88M
2014-12-31	3,218,392.6	$27.69T	$8.6M
2014-09-30	23,712,245.27	$12.8T	$539,874.00
2014-06-30	-3,916,131.92	$11.49T	-$2.93M
2014-03-31	-1,544,462.54	$11.34T	-$7.34M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	1.55	$1.98M	$1.28M
2025-12-31	0.26	$697,219.02	$2.67M
2024-12-31	-1.76	$3.27M	-$1.86M
2023-12-31	2.14	$15.61M	$7.28M
2022-12-31	22.93	$1.14B	$49.86M
2021-12-31	934.42	$86.9B	$93M
2020-12-31	1,730.86	$70.14B	$40.52M
2019-12-31	1,290.6	$20.15B	$15.62M
2018-12-31	2,827.02	$4.88B	$1.72M
2017-12-31	533,103.89	$1.97T	$3.7M
2016-12-31	7,177,669.4	$42.19T	$5.88M
2015-12-31	4,722,590.73	$23.54T	$4.98M
2014-12-31	3,218,392.6	$27.69T	$8.6M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Transcode Therapeutics, Inc. (RNAZ)	United States	$0.029B	-0.12
KYNTRA BIO, INC. (KYNB)	United States	$0.028B	0.17
IGC Pharma, Inc. (IGC)	United States	$0.029B	-5.98
BeyondSpring Inc. (BYSI)	United States	$0.031B	-10.95
NANOVIRICIDES, INC. (NNVC)	United States	$0.031B
CHINA PHARMA HOLDINGS, INC. (CPHI)		$0.032B
AYTU BIOPHARMA, INC (AYTU)	United States	$0.025B	-1.62
Propanc Biopharma, Inc. (PPCB)		$0.032B	-0.13
NextCure, Inc. (NXTC)	United States	$0.024B	-0.15
TherapeuticsMD, Inc. (TXMD)	United States	$0.024B	-117.87